M&A Group Of The Year: Latham & Watkins
The mergers and acquisitions team at Latham & Watkins LLP posted yet another strong year that was boosted by a $40.5 billion deal to sell Allergan's generic drugs business and a...To view the full article, register now.
Already a subscriber? Click here to view full article